Shahzad Malik, Director at Aravive, holds 1.62M shares in Acutus Medical (Ticker: AFIB), holds 1.70M shares in Axonics Modulation Technologies (Ticker: AXNX), holds 1.65M shares in Aravive (Ticker: ARAV).
Shahzad Malik latest transaction was an Uninformative Buy of ―.
What was Shahzad Malik's most profitable transaction?
Shahzad Malik’s most profitable transaction was an Informative Sell of ARAV stock on March 17, 2017. The return on the trade was 90.50%.
What is Shahzad Malik's role in Aravive?
Shahzad Malik's role in Aravive is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.